Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Chitogenx Inc C.CHGX

Alternate Symbol(s):  CHNXF

ChitogenX Inc. is a Canada-based emerging orthopedic and sports medicine biologics company. The Company is engaged in the development of therapeutic soft tissue repair technologies to improve the success rate of orthopedic and sports medicine surgeries. The Company’s proprietary biopolymer has been specifically designed to increase the healing rates of occupational and sports related injuries... see more

Recent & Breaking News (CSE:CHGX)

CHITOGENX ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

Canada NewsWire February 28, 2024

CHITOGENX REPORTS THIRD QUARTER 2024 RESULTS

Canada NewsWire January 3, 2024

CHITOGENX DEMONSTRATES ORTHO-R EFFICACY AND OSTEOARTHRITIS PROTECTION IN LARGE ANIMAL MENISCAL REPAIR STUDY

Canada NewsWire November 9, 2023

CHITOGENX LAUNCHES BURN AND SKIN REPAIR DEVELOPMENT PROGRAM

PR Newswire November 7, 2023

CHITOGENX REPORTS SECOND QUARTER 2024 RESULTS

Canada NewsWire September 29, 2023

CHITOGENX RECEIVES NOTICE OF ALLOWANCE FOR KEY PATENT IN UNITED STATES AND CANADA

Canada NewsWire September 28, 2023

CHITOGENX CONCLUDES ENROLMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

Canada NewsWire September 26, 2023

CHITOGENX ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS

Canada NewsWire August 2, 2023

CHITOGENX REPORTS FIRST QUARTER 2024 RESULTS

Canada NewsWire June 30, 2023

CHITOGENX RETAINS BRUDER CONSULTING & VENTURE GROUP TO BROADEN AND ACCELERATE ONGOING STRATEGIC DEVELOPMENT PARTNERSHIP DISCUSSIONS

Canada NewsWire June 15, 2023

CHITOGENX CLOSES $288,000 SECOND TRANCHE OF NON-BROKERED PRIVATE PLACEMENT OFFERING

Canada NewsWire June 5, 2023

CHITOGENX REPORTS 2023 FISCAL YEAR-END RESULTS

Canada NewsWire May 31, 2023

CHITOGENX CLOSES $3.9 MILLION NON-BROKERED PRIVATE PLACEMENT OFFERING

Canada NewsWire May 5, 2023

CHITOGENX AMENDS TERMS OF PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT

Canada NewsWire May 1, 2023

CHITOGENX ANNOUNCES CHANGE OF AUDITORS

Canada NewsWire April 14, 2023

CHITOGENX ANNOUNCES NEW $2.5 MILLION NON-BROKERED PRIVATE PLACEMENT OFFERING AND BALANCE SHEET RESTRUCTURING

Canada NewsWire April 4, 2023

CHITOGENX ANNOUNCES $3.5 MILLION GRANT TO ADVANCE ORTHO-R COMMERCIAL DEVELOPMENT

Canada NewsWire February 16, 2023

CHITOGENX DEMONSTRATES ORTHO-R RESIDENCY PROPERTIES IN MENISCUS STUDY

Canada NewsWire February 14, 2023

CHITOGENX ANNOUNCES UP TO $4.35 MILLION PRIVATE PLACEMENT PURSUANT TO THE LISTED ISSUER EXEMPTION

Canada NewsWire February 9, 2023

CHITOGENX REPORTS ITS THIRD QUARTER 2023 RESULTS

Canada NewsWire December 29, 2022